Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Pharmaceutical drugs stories

Oct 23, 2026

UK approves Johnson & Johnson's oral psoriasis pill for moderate-to-severe plaque psoriasis

Britain's medicines regulator approved Johnson & Johnson's daily pill for adults and teenagers with moderate-to-severe plaque psoriasis, a skin condition causing red, scaly and often itchy patches.

Oct 23, 2026·2 sources
00

Top claims

  • ▪Plaque psoriasis causes red, scaly, and often itchy or painful skin patches
  • ▪Icotyde requires patients to be at least 12 years old and weigh a minimum of 40 kg to meet UK eligibility criteria
  • ▪The Medicines and Healthcare products Regulatory Agency approved Icotyde for adults and teenagers aged 12 and older who weigh at least 40 kg

Subtopics

Autoimmune disease1Autoimmune disease treatments1Drug approval process1Drug Policy, Pricing & Approval1Pharmaceutical Industry1

Related timelines

AI Data Center Gold Rush

111 stories

Congress

110 stories

Congress

110 stories

Crypto hacks

100 stories

Payments

118 stories